Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NephroGenex, Inc. (NRX)
|
Add to portfolio |
|
|
|
| Price: |
$0.51
| | Metrics |
| OS: |
12.9
|
M
| |
-205
|
% ROE
|
| Market cap: |
$6.6
|
M
| |
|
|
|
Net cash:
|
$15.2
|
M
| |
$1.18
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($22.3)
|
M
| |
|
|
|
EBIT
|
($22.3)
|
M
| |
|
|
| EPS |
($2.43)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 0.0 | 0.0 | 0.0 | 2.4 | 2.1 |
| Revenue growth | | | -100.0% | 9.8% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 2.4 | 2.1 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | 0.0% | 0.0% |
| Research and development | 15.3 | 11.3 | 1.5 | | |
| General and administrative | 7.0 | 5.3 | 1.0 | 0.3 | 0.5 |
| EBIT | -22.3 | -16.6 | -2.5 | -2.7 | -2.6 |
| EBIT margin | | | | -114.9% | -122.5% |
| Pre-tax income | -22.9 | -16.8 | -6.3 | -2.9 | -1.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -22.9 | -16.8 | -6.3 | -2.9 | -1.9 |
| Net margin | | | | -123.5% | -86.4% |
| |
| Diluted EPS | ($2.29) | ($2.15) | ($19.71) | ($9.08) | ($5.79) |
| Shares outstanding (diluted) | 10.0 | 7.8 | 0.3 | 0.3 | 0.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|